THE equine industry, already reeling from the deadly effects of African horse sickness (AHS) and the overseas sanctions that come with it, has been blamed for the ongoing shortage of vaccine to combat the disease.
This week Onderstepoort Biological Products (OBP), the parastatal which manufactures the vaccine, refused to take responsibility